(1 - 23 von 28
)
Risikokapital für Schweizer Proteomik-Leader
www.pressetext.com
"Der Abschluss dieser Finanzierungsrunde widerspiegelt das Vetrauen ins Biognosys Team und unsere Targeted-Proteomics-Technologie," sagt Biognosys CEO Oliver Rinner.
Swiss proteomics leader got venture capital - Newsfoxwww.newsfox.com › news
www.newsfox.com
[ download press photo ], title: Oliver Rinner at a conference image text: Biognosys CEO tells the crowd in Denver why targeted proteomics is the future copyright: ...
Proteómica de cerca: una entrevista con el Dr. Oliver Rinnerwww.news-courier.com › proteomics › articles › pro...
www.news-courier.com
· Recientemente hablamos con el Dr. Oliver Rinner, CEOen Biognosys, para obtener más información sobre los desarrollos más recientes en el ...
Biognosys Announces Strategic Agreement with Siemens Healthineers |...
financialpost.com
· Oliver Rinner, PhD, CEO and founder of Biognosys states: · The strategic agreement enables discovery of novel biomarkers via the HRM technology ...
sortiert nach Relevanz / Datum